LXRX - Lexicon Pharmaceuticals GAAP EPS of -$0.20 in-line revenue of $1.13M misses by $0.27M
2024-05-02 16:32:39 ET
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals: Moving To Maximize The Value Of Its Core Asset
- Lexicon Pharmaceuticals Q1 2024 Earnings Preview
- Lexicon stock slides 8% after rallying 30% in prior session
- Seeking Alpha’s Quant Rating on Lexicon Pharmaceuticals
- Historical earnings data for Lexicon Pharmaceuticals